Pablo Rusjan

10.4k total citations · 1 hit paper
152 papers, 7.6k citations indexed

About

Pablo Rusjan is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Pharmacology. According to data from OpenAlex, Pablo Rusjan has authored 152 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Cellular and Molecular Neuroscience, 37 papers in Biological Psychiatry and 34 papers in Pharmacology. Recurrent topics in Pablo Rusjan's work include Neurotransmitter Receptor Influence on Behavior (47 papers), Tryptophan and brain disorders (37 papers) and Neuroscience and Neuropharmacology Research (29 papers). Pablo Rusjan is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (47 papers), Tryptophan and brain disorders (37 papers) and Neuroscience and Neuropharmacology Research (29 papers). Pablo Rusjan collaborates with scholars based in Canada, United States and Australia. Pablo Rusjan's co-authors include Sylvain Houle, Alan A. Wilson, Romina Mizrahi, Jeffrey H. Meyer, Isabelle Boileau, Ivonne Suridjan, Antonio P. Strafella, Stephen J. Kish, Laura Miler and Anthony E. Lang and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Pablo Rusjan

146 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of Translocator Protein Density, a Marker of Neuroinflammation, in the Brain During Major Depressive Episodes

2015 685 citations Elaine Setiawan, Alan A. Wilson et al. JAMA Psychiatry profile →

Peers

Countries citing papers authored by Pablo Rusjan

Since Specialization

Citations

This map shows the geographic impact of Pablo Rusjan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Rusjan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Rusjan more than expected).

Fields of papers citing papers by Pablo Rusjan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Rusjan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Rusjan. The network helps show where Pablo Rusjan may publish in the future.

Co-authorship network of co-authors of Pablo Rusjan

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Rusjan. A scholar is included among the top collaborators of Pablo Rusjan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Rusjan. Pablo Rusjan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use 2025 ·Drug and Alcohol Dependence Reports ·Rachel A. Rabin, (unknown), Ranjini Garani Ramesh, Romina Mizrahi, Pablo Rusjan	0
2	Fatty acid amide hydrolase in major depressive episodes: A [11C]CURB positron emission tomography study 2025 ·Neuropsychopharmacology ·(unknown), (unknown), Jeffrey H. Meyer, Kimberly L. Desmond, Ruth A. Ross, Isabelle Boileau, Jerry J. Warsh, Pablo Rusjan, Neil Vasdev, (unknown), (unknown), Nathan J. Kolla	1
3	Evidence of altered monoamine oxidase B, an astroglia marker, in early psychosis and high-risk state 2024 ·Molecular Psychiatry ·(unknown), (unknown), (unknown), Reza Rahimian, Naguib Mechawar, Gustavo Turecki, (unknown), Isabelle Boileau, Jeffrey H. Meyer, Pablo Rusjan, Romina Mizrahi	3
4	Synaptic Density in Early Stages of Psychosis and Clinical High Risk 2024 ·JAMA Psychiatry ·(unknown), (unknown), (unknown), Ilana R. Leppert, Christine Tardif, (unknown), Pablo Rusjan, Romina Mizrahi	3
5	Astrogliosis marker 11C-SL25.1188 PET in traumatic brain injury with persistent symptoms 2023 ·Brain ·Yuko Koshimori, Michael D. Cusimano, Érica Leandro Marciano Vieira, Pablo Rusjan, Stephen J. Kish, Neil Vasdev, Sho Moriguchi, Isabelle Boileau, (unknown), (unknown), Muhammad Ishrat Husain, (unknown), (unknown), Jeffrey H. Meyer	5
6	Development of a minimally invasive simultaneous estimation method for quantifying translocator protein binding with [18F]FEPPA positron emission tomography 2023 ·EJNMMI Research ·(unknown), Udunna Anazodo, Linshan Liu, (unknown), (unknown), Justin W. Hicks, Pablo Rusjan, Elizabeth Finger, Keith St. Lawrence	2
7	Lower amygdala fatty acid amide hydrolase in violent offenders with antisocial personality disorder: an [11C]CURB positron emission tomography study 2021 ·Translational Psychiatry ·Nathan J. Kolla, Isabelle Boileau, (unknown), Jeremy J. Watts, Pablo Rusjan, Sylvain Houle, Romina Mizrahi	18
8	A double-blind placebo-controlled trial of minocycline on translocator protein distribution volume in treatment-resistant major depressive disorder 2021 ·Translational Psychiatry ·Sophia Attwells, Elaine Setiawan, Pablo Rusjan, Cynthia Xu, Stephen J. Kish, Neil Vasdev, Sylvain Houle, (unknown), Jeffrey H. Meyer	16
9	Personality traits in psychosis and psychosis risk linked to TSPO expression: a neuroimmune marker 2020 ·SHILAP Revista de lepidopterología ·Cory Gerritsen, (unknown), (unknown), (unknown), Pablo Rusjan, R. Michael Bagby, Romina Mizrahi	1
10	Elevated fatty acid amide hydrolase in the prefrontal cortex of borderline personality disorder: a [11C]CURB positron emission tomography study 2020 ·Neuropsychopharmacology ·Nathan J. Kolla, Romina Mizrahi, (unknown), (unknown), R. Michael Bagby, Shelley McMain, Alexander I. F. Simpson, Pablo Rusjan, Rachel F. Tyndale, Sylvain Houle, Isabelle Boileau	29
11	PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers 2020 ·Frontiers in Neurology ·(unknown), Foad Taghdiri, Namita Multani, Cassandra Jessica Anor, Karen Misquitta, Sylvain Houle, (unknown), David F. Tang‐Wai, Anthony E. Lang, Susan H. Fox, Elizabeth Slow, Pablo Rusjan, Maria Carmela Tartaglia	8
12	Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study 2018 ·The Lancet Psychiatry ·Elaine Setiawan, Sophia Attwells, Alan A. Wilson, Romina Mizrahi, Pablo Rusjan, Laura Miler, Cynthia Xu, Sarita Sharma, Stephen J. Kish, Sylvain Houle, Jeffrey H. Meyer	163
13	Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson’s disease 2017 ·Brain ·Nancy J. Butcher, Connie Marras, Margarita Pondal, Pablo Rusjan, Erik Boot, Leigh Christopher, Gabriela M. Repetto, Rosemarie Fritsch, Eva W.C. Chow, Mario Masellis, Antonio P. Strafella, Anthony E. Lang, Anne S. Bassett	34
14	Greater Monoamine Oxidase A Binding in Perimenopausal Age as Measured With Carbon 11–Labeled Harmine Positron Emission Tomography 2014 ·JAMA Psychiatry ·P. Vivien Rekkas, Alan A. Wilson, (unknown), (unknown), Julia Sacher, Pablo Rusjan, Sylvain Houle, Donna E. Stewart, Nathan J. Kolla, Stephen J. Kish, (unknown), Jeffrey H. Meyer	58
15	Image Derived Input Function for [18F]-FEPPA: Application to Quantify Translocator Protein (18 kDa) in the Human Brain 2014 ·PLoS ONE ·Rostom Mabrouk, Pablo Rusjan, Romina Mizrahi, Mark F. Jacobs, Yuko Koshimori, Sylvain Houle, Ji Hyun Ko, Antonio P. Strafella	11
16	Presentation of Smoking-Associated Cues Does Not Elicit Dopamine Release after One-Hour Smoking Abstinence: A [11C]-(+)-PHNO PET Study 2013 ·PLoS ONE ·(unknown), Isabelle Boileau, (unknown), Pablo Rusjan, Alan A. Wilson, Laurie Zawertailo, Sylvain Houle, Usoa Busto, Bernard Le Foll	11
17	Higher Binding of the Dopamine D ₃ Receptor-Preferring Ligand [ ¹¹ C]-(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography Study 2012 ·Journal of Neuroscience ·Isabelle Boileau, Doris Payer, Sylvain Houle, Arian Behzadi, Pablo Rusjan, Junchao Tong, Diana G. Wilkins, Peter Selby, Tony P. George, Martin Zack, Yoshiaki Furukawa, Tina McCluskey, Alan A. Wilson, Stephen J. Kish	143
18	Increased Vesicular Monoamine Transporter Binding during Early Abstinence In Human Methamphetamine Users: Is VMAT2 a Stable Dopamine Neuron Biomarker? 2008 ·Journal of Neuroscience ·Isabelle Boileau, Pablo Rusjan, Sylvain Houle, Diana G. Wilkins, Junchao Tong, Peter Selby, Mark Guttman, Jean A. Saint‐Cyr, Alan A. Wilson, Stephen J. Kish	73
19	Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography 2007 ·Psychopharmacology ·Aristotle N. Voineskos, Alan A. Wilson, (unknown), Sandra Sagrati, Sylvain Houle, Pablo Rusjan, Stephen T.H. Sokolov, Edgar P. Spencer, Nathalie Ginovart, Jeffrey H. Meyer	46
20	A Positron Emission Tomography Study of 5-Hydroxytryptamine-1A Receptors in Alzheimer Disease 2007 ·American Journal of Geriatric Psychiatry ·Krista L. Lanctôt, Doug Hussey, Nathan Herrmann, Sandra E. Black, Pablo Rusjan, Alan A. Wilson, Sylvain Houle, Nicole Kozloff, Nicholaas Paul L.G. Verhoeff, Shitij Kapur	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact